Intranasal administration of mesenchymal stem cells overexpressing FGF21 demonstrates therapeutic potential in experimental Parkinson's disease

Shih‐Ya Hung(China Medical University)
Neurotherapeutics
November 27, 2024
Cited by 7


Related Papers